Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 3.010
+0.080 (2.73%)
Jan 16, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 529.9 million as of January 16, 2026. Its market cap has increased by 118.67% in one year.
Market Cap
529.90M
Enterprise Value
516.24M
Revenue
6.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.01
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 529.90M, an increase of 4,093.19%. That is a compound annual growth rate of 48.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 529.90M | 7.35% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.64B |
| Pro Medicus | 22.19B |
| Cochlear | 17.45B |
| Sonic Healthcare | 11.45B |
| Ramsay Health Care | 8.45B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.76B |
| Mesoblast | 3.45B |